[New therapeutic target of breast cancer].
Kubo
Makoto
M
Department of Clinical Oncology and Surgery, Graduate School of Medical Sciences, Kyushu University.
Kuroki
Syoji
S
Tanaka
Masao
M
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000209:etiology* / Q000473:pathology / Q000628:therapy*; D005260:Female; D053823:Hedgehog Proteins / Q000037:antagonists & inhibitors / Q000502:physiology*; D006801:Humans; D014411:Neoplastic Stem Cells / Q000473:pathology; D015513:Oncogene Proteins / Q000037:antagonists & inhibitors / Q000502:physiology; D000072079:Patched Receptors; D011956:Receptors, Cell Surface / Q000037:antagonists & inhibitors / Q000502:physiology; D015398:Signal Transduction / Q000502:physiology*; D015534:Trans-Activators / Q000037:antagonists & inhibitors / Q000502:physiology; D014704:Veratrum Alkaloids / Q000494:pharmacology / Q000627:therapeutic use; D000071676:Zinc Finger Protein GLI1
D000970:Antineoplastic Agents; D053823:Hedgehog Proteins; D015513:Oncogene Proteins; D000072079:Patched Receptors; D011956:Receptors, Cell Surface; D015534:Trans-Activators; D014704:Veratrum Alkaloids; D000071676:Zinc Finger Protein GLI1; C000541:cyclopamine